2019

A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response.
Denker, S. ORCID: https://orcid.org/0000-0002-0736-6019, Bittner, A. ORCID: https://orcid.org/0000-0001-6434-0950, Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424, Kase, J., Frick, M., Anagnostopoulos, I., Hummel, M. and Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
International Journal of Hematologic Oncology 8 (4): IJH20. 19 December 2019